These celebrities with HIV are proving that you can thrive and enjoy life after an HIV diagnosis. Here, their hopes for ...

Hetero and Dr Reddy’s — will be funded by the Gates Foundation and Unitaid, respectively, to produce and sell the twice-a-year anti-HIV shot, lenacapavir, for $40 (around R692) per person per ...

Key Takeaways FDA has launched an aggressive new crackdown on direct-to-consumer (DTC) drug advertising, issuing nearly 100 cease-and-desist letters and thousands of notices — many targeting ...

Walmsley, who became CEO of the U.K. drugmaker in 2017 and is due to step down at the end of the year, led GSK through the Covid-19 pandemic, a fight with activist investor Elliott Management, and a ...

The injectable, Lenacapavir, is expected to play a key role in efforts to eliminate HIV, following UNAIDS’ call for countries to end the epidemic amid funding challenges.

Being out of care doesn’t have to be permanent, and many people can restart HIV treatment. The sooner PWH restart treatment, ...

The CDC made a strong recommendation based on a high certainty of evidence to use the long-acting injectable lenacapavir ...

Two partnerships will provide millions of people access to what is widely described as the most effective HIV prevention drug ...

Attorney General James Uthmeier announced on Wednesday that a $3 million settlement agreement with Gilead Sciences, Inc.

A game-changing HIV prevention drug is set to become vastly more affordable in over 100 low- and middle-income countries, a move that could bring the world closer to ending the HIV/AIDS epidemic.

A Lehigh Valley company that helped transform HIV testing is continuing its mission to improve public health through innovation and accessibility.

University of Maine researchers developed a new process to make HBL, a key ingredient in many medicines, from renewable ...